Site icon pharmaceutical daily

India Over the Counter Drugs (OTC) Market Growth, Trends, and Forecasts 2019-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India
Over the Counter Drugs (Otc) Market- Growth, Trends, and Forecast (2019
– 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The key factors propelling the growth of the Indian over-the-counter
drugs market are the shift in consumer attitude toward self-medication,
product innovations, and inclination of pharmaceutical companies toward
OTC drugs from RX drugs.

India is one of the emerging markets for OTC drugs and offers
significant growth potential for the industry. The market is growing in
India due to the increasing healthcare expenditure, unhealthy dietary
habits, expanding population, and growing healthcare awareness.

The increasing disposable income of people, along with a shift in the
consumer attitude toward self-medication and increasing geriatric
population are the two major factors driving the overall market in the
region. Thus, the increasing awareness about the cost-effectiveness of
self-medication and OTC medicines is also a crucial factor fueling the
market growth.

There is also the rapidly growing population, which is coupled with the
fact that the middle class in these regions is expanding on a large
scale, which may add critical mass to the population available to access
OTC medication. Thus, the increasing investments of market giants in the
emerging market are expected to drive the growth of the overall market.

Scope of the Report

As per the scope of the report, over-the-counter drugs are referred to
as the non-prescription drugs. These medicines can be bought by
individuals without a doctor’s prescription and are safe for consumption
without the doctor’s consent. There are a wide number of therapeutic
applications for OTC drugs ranging from weight control drugs to
analgesic drugs, and many more.

Key Market Trends

Analgesics is the Segment by Product that is Expected to Grow the
Largest During the Forecast Period

Analgesics accounted for a significant value share of the
over-the-counter (OTC) drugs market. OTC analgesics are found to have
several applications in the treatment of fever, headache,
musculoskeletal injuries and disorders, arthritis, and menstrual cramps
that have spurred the overall demand in the market. Other factors, such
as obesity, stress, and lifestyle disorders lead to chronic pain and
different kinds of aches. The population is widespread in the developed
markets, as well as in high economic growth countries, such as India,
China. Therefore, in these countries, the population contributes to the
increasing demand and growth of analgesics in the market.

Competitive Landscape

The industry players are found focusing on new product development and
acquisition strategies to gain market share. The developing countries
have also opened new growth avenues for pharmaceutical companies. Thus
the market has different challenges and requires innovative products
facilitating new innovative OTC drugs.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Market Overview

4.2 Market Drivers

4.2.1 Shift In Consumer Attitude Toward Self Medication

4.2.2 Product Innovations

4.2.3 Inclination of Pharmaceutical Companies Toward OTC Drugs from RX
Drugs

4.3 Market Restraints

4.3.1 Price Cuts for Various Ingredients and Restrictions for Advertising

4.3.2 Lack of Specific Regulations for OTC Drugs

4.4 Porter’s Five Forces Analysis

5 Market Segmentation

5.1 By Product

5.1.1 Cough, Cold, and Flu Products

5.1.2 Analgesics

5.1.3 Dermatology Products

5.1.4 Gastrointestinal Products

5.1.5 Vitamins, Minerals, and Supplements (VMS)

5.1.6 Other Products

5.2 By Distribution Channel

5.2.1 Retail Pharmacies

5.2.2 Online Pharmacy

5.2.3 Other Distribution Channels

6 Competitive Landscape

6.1 Company Profiles

6.1.1 GlaxoSmithKline PLC

6.1.2 Emami Limited

6.1.3 Abbott Laboratories

6.1.4 Dabur India Limited

6.1.5 Procter & Gamble

6.1.6 Reckitt Benckiser

6.1.7 Sun Pharmaceuticals Limited

6.1.8 Cipla Inc.

6.1.9 Takeda Pharmaceutical Company

7 Market Opportunities and Future Trends

For more information about this report visit https://www.researchandmarkets.com/research/nrx65b/india_over_the?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Over
the Counter (OTC) Drugs

Exit mobile version